Letter:
Dear editor,
It was an enormous delight to read the article ”Intraoperative renal
hypoxia and risk of cardiac surgery-associated acute kidney injury” by
Jennifer P. Ngo et Al.1 The author’s endeavors are
admired concerning this important topic and need to be acknowledged by
the readers. We agree with the conclusion of the study that urinary
oxygen tension (UPO2) strongly predicts renal injury post-cardiac
surgery. In contrast, plasma erythropoietin (pEPO) does not show an
association with renal injury. However, few concerns have been
interrupting the validity of the study.
Firstly, as well known, viscosity is associated with decreased supply of
blood to the organs and therefore causes hypoperfusion of the organs and
ischemia resulting in organ damage. Therefore the authors should have
included hemodilution as one variable since hemodilution decreases the
viscosity. For example, a 2006 study included hemodilution as one of the
steps in the surgical procedure and found out hemodilution increases the
risk of renal injury.2 Additionally, not including
participants from different demographics has been found to be associated
with the difference in the study’s outcomes. For illustration, a study
in 2008 included black and white participants that strengthened their
study and supported their findings.3
Moreover, this study’s small sample size could alter the authenticity of
the study’s outcomes. This is why the authors should have opted to
include a large number of participants. For example, a 2011 study
included 1219 participants in their study, which increased their study’s
efficacy.4 Lastly, the authors should also have looked
for additional laboratory values of endotoxins and elevated levels of
tumor necrosis factor-alpha. They should have excluded the use of some
nephrotoxic drugs and nonsteroidal anti-inflammatory drugs because of
their strong relation to causing injury to the kidney. For illustration,
a study in 2012 found a positive association of their factors with renal
injury.5